FINWIRES · TerminalLIVE
FINWIRES

Incentives Drive Canada's Rebound in Electric Vehicle Sales, Says BMO

-- If there were any doubts that Canadian consumers remain "highly price sensitive", the February zero-emission vehicle (ZEV) sales data should put them to rest, said Bank of Montreal (BMO) in an overnight note.

After significantly underperforming over the past year, down roughly 36% year over year, or more than 94,000 units, the final 13 days of February, which followed the reinstatement of federal incentives, were enough to drive ZEV sales up 47% year over year, noted the bank.

That pushed ZEVs back above 10% of new vehicle sales, up from less than 7% a year ago.

"With the conflict in Iran pushing global energy prices higher in March, ZEV sales could see further near-term support when that data is released," added BMO.

Regionally, it was overwhelmingly a Quebec story, with ZEV sales up a "staggering" 153% year over year, versus roughly 17% in Ontario and about 5% in British Columbia, noted out the bank.

Further evidence of price sensitivity comes from the United States, where ZEV sales fell 19% year over year in February as the loss of federal tax credits continued to reshape demand, according to BMO. While the segment showed some month-over-month improvement in March, sales were still down more than 30% year over year, it said.

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR